Viruses

Hear from Meivan Yang, a UArizona Junior who is majoring in Bioinformatics and Biochemistry. She has worked in Dr. Goodrum’s lab since the Summer of 2021, where they study Human Cytomegalovirus (HCMV).

New boosters that target Omicron may be our most important COVID vaccines since the beginning of the pandemic in 2020- with inoculations that are proven to be well matched to the season’s circulating strains providing hope into the winter season.

Drugmakers Pfizer and BioNTech announced that they've asked the Food and Drug Administration to authorize an updated version of their COVID-19 vaccine — this one designed specifically to target the omicron subvariants that are dominant in the U.S.

The U.S. is one step closer to having new COVID-19 booster shots available as soon as this fall.

Dr. Felicia Goodrum, a professor in the UArizona College of Medicine – Tucson’s Department of Immunobiology, has been appointed co-editor-in-chief of the American Society for Microbiology’s Journal of Virology.

Experts from around the US, including UArizona researcher Dr. Deepta Bhattacharya, weigh in on how many times you can get infected with COVID-19 and why.

Dr. Janko Nikolich-Žugich’s past experiences left him uniquely prepared to fight a global pandemic – and help prevent the next one.

The Center for Disease Control is awarding the UArizona AZ HEROS study $22 million to keep studying COVID-19 into its third year.

An international team of researchers has confirmed that live animals sold at the Huanan Seafood Wholesale Market in Wuhan, China, were the likely source of the COVID-19 pandemic that has claimed 6.4 million lives since it began nearly three years ago.

CDC funding will allow research on COVID-19 immunity and vaccine effectiveness to continue as new variants emerge.